Chemoinformaics analysis of 9-Octylheptadecane
| Molecular Weight | 352.691 | nRot | 21 |
| Heavy Atom Molecular Weight | 300.275 | nRig | 2 |
| Exact Molecular Weight | 352.407 | nRing | 0 |
| Solubility: LogS | -4.544 | nHRing | 0 |
| Solubility: LogP | 4.472 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 77 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 25 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 52 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 25 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 76.4232 |
| nHD | 0 | BPOL | 52.1668 |
| QED | 0.475 |
| Synth | 2.888 |
| Natural Product Likeliness | 1.552 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.665 |
| Pgp-sub | 0.003 |
| HIA | 0.003 |
| CACO-2 | -4.376 |
| MDCK | 0.0000251 |
| BBB | 0.401 |
| PPB | 0.968543 |
| VDSS | 1.576 |
| FU | 0.034718 |
| CYP1A2-inh | 0.977 |
| CYP1A2-sub | 0.255 |
| CYP2c19-inh | 0.707 |
| CYP2c19-sub | 0.5 |
| CYP2c9-inh | 0.542 |
| CYP2c9-sub | 0.715 |
| CYP2d6-inh | 0.041 |
| CYP2d6-sub | 0.113 |
| CYP3a4-inh | 0.14 |
| CYP3a4-sub | 0.216 |
| CL | 15.311 |
| T12 | 0.435 |
| hERG | 0.018 |
| Ames | 0.004 |
| ROA | 0.012 |
| SkinSen | 0.943 |
| Carcinogencity | 0.226 |
| EI | 0.933 |
| Respiratory | 0.241 |
| NR-Aromatase | 0.006 |
| Antiviral | No |
| Prediction | 0.749581 |